Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions—A Longitudinal Mixed-Methods Study Exploring the Patient Perspective
Pharmacogenetic (PGx) testing is a promising approach for optimizing drug therapies. However, there is limited knowledge regarding its real-world utilization and long-term impact in clinical practice. This study assessed how often PGx information informs treatment decisions and evaluated patients’ p...
Saved in:
| Main Authors: | Anna Bollinger, Melissa Semedo Fortes, Henriette E. Meyer zu Schwabedissen, Kurt E. Hersberger, Céline K. Stäuble, Samuel S. Allemann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Pharmacy |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2226-4787/13/1/14 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Pharmacogenetics of psychiatric disorders
by: Sarah Allegra, et al.
Published: (2025-01-01) -
Association of Pharmacogenotyping and Patient-Reported Outcomes in Chronic Pain Management
by: Anna Bollinger, et al.
Published: (2025-07-01) -
Pharmacogenomic testing implementation: Tertiary care center experience and results of a pilot of 512 patients
by: Dana Bakheet, et al.
Published: (2025-01-01) -
Editorial: Editor’s feature: negative findings in pharmacogenetics and pharmacogenomics volume II
by: José A. G. Agúndez, et al.
Published: (2025-07-01) -
Unveiling the heritability of selected unexplored pharmacogenetic markers in the Saudi population
by: Mohammad A. Alshabeeb, et al.
Published: (2025-05-01)